Influence of smoking in the glutathione-S-transferase M1 deficiency-associated risk for squamous cell carcinoma of the bladder in schistosomiasis patients in Egypt

British Journal of Cancer

Volumn 74, Issue 5, 1996, Pages 836-838

  Lafuente, A ^a   Zakahary, M M ^b   El Aziz, M A A ^b   Ascaso, C ^a   Lafuente, M J ^a   Trias, M ^a   Carretero, P ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Assiut University Faculty of Medicine   (Egypt)

Author keywords

Bladder cancer; Free radical; Glutathione S transferase; Schistosomiasis

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER RISK; CONTROLLED STUDY; EGYPT; ENZYME DEFICIENCY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHISTOSOMIASIS; SMOKING; SQUAMOUS CELL CARCINOMA;

EID: 0029777386     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.445     Document Type: Article

References (23)

1. ANTTILA S, LUOSTARINEN L, HIRVONEN A, ELOVAARA E, KARJALAINEN A, NURMINEN T, HAYES JD, VAINIO H AND KETTERER B. (1995). Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymoprhism, smoking and asbestos exposure. Cancer Res., 55, 3305-3309.
2. BADAWI AF, MOSTAFA MH AND O'CONNOR PJ. (1992). Involvement of alkylating agents in schistosome-associated bladder cancer: the possible basic mechanisms of induction. Cancer Lett., 63, 171-188.
3. BELL DA, TAYLOR JA, PAULSON DF, ROBERTSON CN, MOHLER JL AND LUCIER GW. (1993). Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst., 85, 1159-1164.
4. BROCKMÖLLER J, KERB R, DRAKOULIS N, NITZ M AND ROOTS I. (1993). Genotype and phenotype of glutathione S-transferase class -mu isoenzymes-mu and isoenzyme-psi in lung cancer patients and controls. Cancer Res., 53, 1004 1011.
5. BROCK MÖLLER J, KERB R, DRAKOULIS N, STAFFELDT B AND ROOTS I. (1994). Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res., 54, 4103-4111.
6. COLE P, MONSON RR, HANING H AND FRIEDELL GH. (1971). Smoking and cancer of the lower urinary tract. N. Engl. J. Med., 284, 129-134.
7. DALY AK, THOMAS DJ, COOPER J, PEARSON WR, NEAL DE AND IDLE JR. (1993). Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. Br. Med. J., 307, 481 482.
8. HABUCHI T, TAKAHASHI R, YAMADA H, OGAWA O, KAKEHI Y, OGURA K, HAMAZAKI S, TOGUCHIDA J, ISHIZAKI K, FUJITA J, SUGIYAMA T AND YOSHIDA O. (1993). Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res., 53, 3795-3799.
9. HAYASHI S, WATANABE J AND KAWAJIRI K. (1992). High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu class Glutathione S transferases genes. Jpn. J. Cancer Res., 83, 866-870.
10. HUSSEY AJ, STOCKMAN PK, BECKETT GJ AND HAYES JD. (1986). Variations in the glutathione S-Transferase subunits expressed in human livers. Biochim. Biophys. Acta, 874, 1-12.
11. IARC. (1986). Tobacco smoking. IARC Monogr. Eval. Carcinog. Risks. Hum., 38, 35-394.
12. IARC. (1994). Schistosomes, liver flukes and Helicobacter pylory. IARC Monogr. Eval. Carcinog. Risks. Hum., 61, 1 241.
13. KENSLER T, STYCZYNSKI P, GROOPMAN J, HELZLSOUER K, CURPHEY T, MAXUITENKO Y AND ROEBUCK BD. (1992). Mechanisms of chemoprotection by Oltipraz. J. Cell. Biochem. (suppl.) 161, 167-172.
14. KETTERER B AND MEYER DJ. (1989). Glutathione transferases: A possible role in the detoxication and repair of DNA and lipid hydroperoxides. Mutat. Res., 214, 33-40.
15. LAFUENTE A, PUJOL F, CARRETERO P, PEREZ VILLA J AND CUCHI A. (1993). Human glutathione S-transferase mu (GSTMU) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett., 68, 49 54.
16. LAFUENTE A, MOLINA R, PALOU J, CASTEL T, MORAL A, TRIAS M, AND MMM GROUP. (1995). Phenotype of glutathione S-transferase mu (GSTM1) and susceptibility to malignant melanoma. Br. J. Cancer, 72, 324 326.
17. LIN HJ, HAN Ch Y, BERNSTEIN DA, HSIAO W, LIN BK AND HARDY S. (1994). Ethnic distribution of the glutathione transferase Mu I-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis, 15, 1077-1081.
18. MAHGOUB A, IDLE JR AND SMITH RL. (1979). A population and familial study of the defective alicyclic hydroxylation of debrisoquine among Egyptians. Xenobiotica, 9, 51 56.
19. RYBERG D, KURE E, LYSTAD S, SKAUG V, STANGELAND L, MERCY I, BORRESEN A AND HAUGEN A. (1994) p53 Mutations in lung tumors: relationship to putative susceptibility markers for cancer. Cancer Res., 54, 1551-1555.
20. SEIDEGARD J, PERO RW, MARKOWITZ MM, ROUSH G, MILLER DG AND BEATTIE EJ. (1990). Isoenzyme(s) of glutathione transferase (class mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis, 11, 33-36.
21. SINGH SV, XU BH, TKALCEVIC GT, GUPTA V, ROBERTS B AND RUIZ P. (1994). Glutathione-linked detoxification pathway in normal and malignant human bladder tissue. Cancer Lett., 77, 15-24.
22. WYNDER EL AND GOLDSMITH R. (1977). The epidemiology of bladder cancer. A second look. Cancer, 40, 1246 1268.
23. ZHONG S, WYLLIE AH, BARNES D, WOLF CR AND SPURR NK. (1993). Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis, 14, 1821-1824.